<DOC>
	<DOCNO>NCT01474018</DOCNO>
	<brief_summary>QR-Bromocriptine add-on treatment insulin metformin management type 2 diabetes result improved glycemic control , reduce exogenous insulin requirement , increase lean fat mass improve pancreatic beta-cell function .</brief_summary>
	<brief_title>QR-Bromocriptine Adjunct Insulin Metformin Treatment Type 2 Diabetes</brief_title>
	<detailed_description>To assess improvement glycemic control , reliance exogenous insulin , improvement lean body mass composition , improvement pancreatic beta-cell function .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Bromocriptine</mesh_term>
	<criteria>1 . Male female patient , age 30 65 year age , 2 . Clinical diagnosis type 2 diabetes least 6 month prior enrollment , 3 . Stable current treatment consist either human recombinant multidose insulin therapy ( MDI ) metformin , 4 . HbA1c 7.512 % , inclusive , 5 . Demonstrated willingness check record blood glucose reading seven time point instruct study protocol . 6 . Medically controlled hypertension , least one antihypertensive 7 . Medically controlled hyperlipidemia , cholesterollowering therapy 8 . BMI &gt; 30 1 . Pregnancy Lactating , 2 . Type 1 Diabetes , 3 . Concomitant use forbidden medication : prescription sympathomimetics ( within seven day screen ) , ergot alkaloid derivative , antimigraine medication , 4 . Patients history drug alcohol abuse within 3 year enrollment , 5 . Patients risk hypotension , include : Recent blood donation within 30 day enrollment , A history syncopal migraine , Significant gastroparesis orthostatic hypotension could signify advanced autonomic neuropathy . 6 . Uncontrolled mental illness especially history psychosis , 7 . Any severe , uncontrolled terminal medical condition investigator feel would interfere patient 's ability participate comply study protocol , 8 . Serum creatinine &gt; 1.4mg/dL female &gt; 1.5mg/dL male would preclude patient take metformin , 9 . LFTs elevate &gt; 3x upper limit normal , 10 . Patients work rotating , vary night shift , 11 . Patient circumstance abnormality ( e.g . blindness history noncompliance ) would interfere interpretation safety efficacy data completion study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>